List of SBIR/STTR awards granted to LARIX BIOSCIENCE LLC
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in July, 2021 for $252,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL149492-01A1 | Phase I | 252,000 | July 1, 2021 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in September, 2019 for $224,981.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA243853-01A1 | Phase I | 224,981 | September 19, 2019 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in September, 2018 for $224,986.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HD096943-01 | Phase I | 224,986 | September 18, 2018 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in September, 2020 for $252,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AR078684-01 | Phase I | 252,000 | September 5, 2020 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in September, 2018 for $224,981.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG061983-01 | Phase I | 224,981 | September 30, 2018 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in September, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS113704-01 | Phase I | 225,000 | September 1, 2019 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in September, 2022 for $385,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HD107719-01A1 | Phase I | 385,000 | September 1, 2022 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in September, 2022 for $275,766.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43GH002390-01A1 | Phase I | 275,766 | September 30, 2022 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in September, 2018 for $224,981.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK120065-01 | Phase I | 224,981 | September 13, 2018 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in May, 2021 for $249,734.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL156695-01A1 | Phase I | 249,734 | May 1, 2021 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in July, 2021 for $252,282.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA261184-01 | Phase I | 252,282 | July 13, 2021 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in September, 2020 for $250,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK126582-01A1 | Phase I | 250,000 | September 14, 2020 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in September, 2022 for $326,205.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG080911-01 | Phase I | 326,205 | September 30, 2022 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in September, 2022 for $300,847.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HD107741-01A1 | Phase I | 300,847 | September 19, 2022 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in January, 2018 for $224,981.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI136181-01 | Phase I | 224,981 | January 1, 2018 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in June, 2020 for $224,924.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL150897-01 | Phase I | 224,924 | June 1, 2020 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in March, 2022 for $259,606.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43MH130224-01 | Phase I | 259,606 | March 1, 2022 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in February, 2015 for $196,091.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM113478-01 | Phase I | 196,091 | February 1, 2015 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in June, 2017 for $224,981.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA217394-01 | Phase I | 224,981 | June 1, 2017 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in August, 2017 for $224,981.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA221400-01 | Phase I | 224,981 | August 11, 2017 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in September, 2017 for $224,393.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK116376-01 | Phase I | 224,393 | September 20, 2017 | |||||||
A SBIR Phase II contract was awarded to LARIX BIOSCIENCE LLC in September, 2017 for $1,489,394.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM113478-02 | Phase II | 1,489,394 | September 1, 2017 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in May, 2023 for $299,865.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI172662-01A1 | Phase I | 299,865 | May 8, 2023 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in September, 2023 for $295,923.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG085728-01 | Phase I | 295,923 | September 18, 2023 | |||||||
A SBIR Phase I contract was awarded to LARIX BIOSCIENCE LLC in September, 2023 for $245,728.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL154880-01A1 | Phase I | 245,728 | September 1, 2023 |
